Point72 Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Sell |
|
|||||
|
2025
Q1 | $31.7M | Sell |
|
|||||
|
2024
Q4 | $41.7M | Sell |
|
|||||
|
2024
Q3 | $113M | Hold |
|
|||||
|
2024
Q2 | $88.3M | Buy |
|
|||||
|
2024
Q1 | $44.9M | Buy |
|
|||||
|
2023
Q4 | $30.5M | Buy |
|
|||||
|
2023
Q3 | $36.7M | Sell |
|
|||||
|
2023
Q2 | $55.5M | Buy |
|
|||||
|
2023
Q1 | $24.1M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5.33M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6.39M | Sell |
|
|||||
|
2021
Q4 | $7.44M | Sell |
|
|||||
|
2021
Q3 | $8.46M | Sell |
|
|||||
|
2021
Q2 | $12M | Buy |
|
|||||
|
2021
Q1 | $5.37M | Buy |
|
|||||
|
2020
Q4 | $4.55M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.15M | Sell |
|
|||||
|
2018
Q1 | $3.6M | Buy |
|